Drug intelligence / Profile preview

Wensan tincture

Development stage
Unknown
Lead developer
Guang'anmen Hospital
Administration
Transdermal
01

Overview

Wensan tincture is a traditional Chinese medicine (TCM) transdermal formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is designed for the treatment of upper respiratory tract infections (URTI), particularly those occurring in winter and spring, and is specifically used to alleviate URTI-related cough. The tincture is part of a "warming and dispersing" (Wensan) therapeutic strategy. In clinical studies, such as the Phase 0 SMART trial (ChiCTR2400080482), it is evaluated as a transdermal therapy compared against oral medications like montelukast sodium and other TCM powders. As a tincture, it is a liquid herbal extract typically applied to the skin to exert localized or systemic effects through acupoint stimulation or percutaneous absorption.

Other names
Wensan Ding温散酊
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)JUN (Transcription factor Jun)PIK3R1 (Phosphoinositide-3-kinase regulatory subunit 1)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)HSP90AA1 (Heat shock protein HSP90-alpha)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Wensan tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wensan tincture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call